Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial

(2012) Christian Philipp Kamm et al.   JOURNAL OF NEUROLOGY

Oxysterols as biomarkers in neurodegenerative diseases

(2011) Valerio Leoni et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

(2011) Per Soelberg Sorensen et al.   LANCET NEUROLOGY

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

(2010) Mansoureh Togha et al.   Multiple Sclerosis Journal

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Oxysterols as markers of neurological disease – a review

(2009) Valerio Leoni   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes

(2008) Olaf Maier et al.   GLIA

Negative Impact of Statins on Oligodendrocytes and Myelin Formation In Vitro and In Vivo

(2008) S. Klopfleisch et al.   JOURNAL OF NEUROSCIENCE

Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis

(2008) G. Birnbaum et al.   NEUROLOGY